{
  "meta": {
    "timestamp": "2025-01-06T08:52:32.427621",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "Maravai Lifesciences Holdings Inc",
      "symbol": "MRVI",
      "analysis": {
        "historical": {
          "risk_score": 65,
          "key_risks": [
            "Post-pandemic revenue decline due to normalization of COVID-19-related demand",
            "Supply chain vulnerabilities and dependence on critical raw materials",
            "Regulatory and competitive pressures in the life sciences sector",
            "Stock performance volatility and declining investor sentiment"
          ],
          "controversies": [
            "Significant revenue decline post-pandemic, raising sustainability concerns",
            "Stock price volatility and analyst downgrades, including a shift to Sell by Goldman Sachs"
          ],
          "environmental_issues": [],
          "social_issues": [
            "Reliance on pandemic-driven revenue highlights the need for diversification to address broader societal health challenges"
          ],
          "governance_issues": [],
          "recommendation": "caution",
          "confidence_score": 80
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "Document - SEC.gov",
              "snippet": "SAN DIEGO, Calif., \u2014 November 7, 2023 \u2014 Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2023, together with other business updates. Recent highlights include:",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:03.806763+00:00",
              "published_date": null,
              "source_hash": "e3cdddfa77fc6f4ad6df1e9a708c6235"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 ...",
              "snippet": "Continued Focus on Expanding Product Portfolio, Market Leadership and Innovation. SAN DIEGO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the fourth quarter and full year ended December 31, 2023, together with ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:03.806890+00:00",
              "published_date": null,
              "source_hash": "9eabd536473a1029effd84dfb70d381e"
            },
            {
              "url": "",
              "title": "EXCLUSIVE-Vaccine reagent vendor Maravai draws private equity ... - Nasdaq",
              "snippet": "Maravai LifeSciences Holdings Inc, a provider of capping reagents for COVID-19 vaccines whose shares plunged after the pandemic ... Maravai last week revised its 2023 revenue guidance down by $20 ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:03.806913+00:00",
              "published_date": null,
              "source_hash": "ae50f070f3317b99c8cee54423a5f888"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences Holdings Inc, MRVI:NSQ profile - FT.com",
              "snippet": "Year on year Maravai LifeSciences Holdings Inc 's revenues fell -67.28% from 883.00m to 288.95m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a gain of 220.21m to a loss of 119.03m.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:03.806928+00:00",
              "published_date": null,
              "source_hash": "5c449199815f0ab43f7a7f3ed9077b53"
            },
            {
              "url": "",
              "title": "4 Analysts Have This To Say About Maravai LifeSciences",
              "snippet": "Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:03.806944+00:00",
              "published_date": null,
              "source_hash": "8adbb05081602d693a0757de491124b5"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences Reports Third Quarter 2024 Financial Results",
              "snippet": "--Maravai LifeSciences Holdings, Inc., a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:03.806958+00:00",
              "published_date": null,
              "source_hash": "b4575e43fdd64d1a30f8c0b892969d57"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences Holdings | MRVI Stock Price, Company ... - Forbes",
              "snippet": "Maravai LifeSciences enables the development of drug therapies, diagnostics and novel vaccines and supports research on human diseases through its portfolio of market-leading companies and ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:03.806970+00:00",
              "published_date": null,
              "source_hash": "c165b06a654824ca365d7d64591e6e9b"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences Holdings Inc | Reuters",
              "snippet": "Laboratory supplies vendor Sartorius AG has approached Maravai LifeSciences Holdings Inc , a U.S. provider of capping reagents for COVID-19 vaccines, with an $11 billion acquisition offer, people ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc regulatory compliance controversies",
              "retrieved_at": "2025-01-06T15:52:11.630162+00:00",
              "published_date": null,
              "source_hash": "9193cb4731b3856a9b739105c74358d1"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences Reports Fourth Quarter and Full Year 2022 ...",
              "snippet": "Base business revenues, excluding COVID-19 related CleanCap\u00ae revenues, were up 67% in the fourth quarter and up 17% for the full year. Announces acquisition of privately-held Alphazyme, LLC, adding critical enzyme manufacturing capabilities to Maravai's Nucleic Acid Production Segment. SAN DIEGO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:03.806994+00:00",
              "published_date": null,
              "source_hash": "e7b992299729b8ea414b6b42fad00345"
            },
            {
              "url": "",
              "title": "Maravai Lifesciences Holdings revenue 2023 | Statista",
              "snippet": "The revenue of Maravai Lifesciences Holdings with headquarters in the United States amounted to 288.94 million U.S. dollars in 2023. The reported fiscal year ends on December 31.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:03.807008+00:00",
              "published_date": null,
              "source_hash": "bd467195d6759f608e416e1b1a24da84"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences Holdings",
              "snippet": "Maravai LifeSciences enables the development of drug therapies, diagnostics and novel vaccines and supports research on human diseases through its portfolio of market-leading companies and ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:06.096166+00:00",
              "published_date": "2024-12-27T21:00:00+00:00",
              "source_hash": "5c76042a943c099fb38383c169a184b1"
            },
            {
              "url": "",
              "title": "The Maravai Lifesciences Holdings Inc Stock Thriller: Decoding the Mystery Behind MRVI's Recent Movements",
              "snippet": "Maravai Lifesciences Holdings Inc (MRVI) stock saw a decline, ending the day at $5.13 which represents a decrease of $-0.24 or -4.47% from the prior close of $5.37. The stock opened at $5.33 and touched a low of $5.",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:06.096272+00:00",
              "published_date": "2024-10-19T12:13:00+00:00",
              "source_hash": "1d40a3202c5bd458f5abdf0ecdd9d465"
            },
            {
              "url": "",
              "title": "Maravai Lifesciences Holdings Inc (MRVI) Stock: Analyzing Its Quiet Power",
              "snippet": "Guggenheim has recently initiated Maravai Lifesciences Holdings Inc (MRVI) stock to Neutral rating, as announced on December 19, 2024, according to Finviz. Earlier, on December 5, 2024, Goldman had reduced the stock from a Neutral to Sell,",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc regulatory compliance controversies",
              "retrieved_at": "2025-01-06T15:52:14.184512+00:00",
              "published_date": "2024-12-27T14:05:00+00:00",
              "source_hash": "b8000fee6d5c9a24f903b16c4df0176e"
            },
            {
              "url": "",
              "title": "Goldman Sachs Downgrades Maravai LifeSciences Holdings (MRVI)",
              "snippet": "The projected annual revenue for Maravai LifeSciences Holdings is 516MM, an increase of 86.22%. The projected annual non-GAAP EPS is 0.60. What is the Fund Sentiment? There are 491 funds or ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:06.096330+00:00",
              "published_date": "2024-12-06T06:18:00+00:00",
              "source_hash": "556d26ab0d4f6261c4788822e48403cb"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences Holdings Inc Ordinary Shares - Class A",
              "snippet": "We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc post-pandemic revenue decline",
              "retrieved_at": "2025-01-06T15:52:06.096353+00:00",
              "published_date": "2024-12-27T00:00:00+00:00",
              "source_hash": "f3a9aab8f46c027553d51a2407e3197f"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences Holdings, Inc. (MRVI)",
              "snippet": "Maravai LifeSciences is a leading life sciences company providing critical products to enable the development of novel vaccines, drug therapies, and diagnostics, and to support research on human diseases. ... Maravai LifeSciences Holdings, Inc. 10770 Wateridge Circle Suite 200 ... Supply chain; Operations; Diversity, equity, and inclusion ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:52:07.551281+00:00",
              "published_date": null,
              "source_hash": "86e37cdd27fdbfe0744c83c5de52b857"
            },
            {
              "url": "",
              "title": "Supply chain - Maravai LifeSciences",
              "snippet": "At Maravai, we pride ourselves on our robust and agile supply chain strategy. With a relentless focus on quality, reliability, and efficiency, we ensure consistent access to our brands' broad portfolios of products and services - and we respond quickly to support discovery and seamless scale-up for their customers.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:52:07.551347+00:00",
              "published_date": null,
              "source_hash": "df32f28c050e560d62ef15db43a21dbb"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences",
              "snippet": "Maravai companies deliver proactive supply chain capacity, offer broad portfolios of products and services, and respond quickly to support discovery and seamless scale-up/scale-out for their customers. ... Maravai LifeSciences and its brands are the proven catalysts for helping deliver novel vaccines, therapeutics and diagnostics with biotech ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:52:07.551362+00:00",
              "published_date": null,
              "source_hash": "d19346f116dbdea872ef2c3f9f67754f"
            },
            {
              "url": "",
              "title": "Presentations :: Maravai LifeSciences Holdings, Inc. (MRVI)",
              "snippet": "Maravai LifeSciences and its brands are the proven catalysts for helping deliver novel vaccines, therapeutics and diagnostics with biotech, biopharma and life sciences companies across the globe. Extraordinary science. Everyday miracles.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:52:07.551373+00:00",
              "published_date": null,
              "source_hash": "06f3a621716e27d2ddbfc2405d5da258"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences Holdings, Inc. (MRVI) - Yahoo Finance",
              "snippet": "Find the latest Maravai LifeSciences Holdings, Inc. (MRVI) stock quote, history, news and other vital information to help you with your stock trading and investing.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:52:07.551383+00:00",
              "published_date": null,
              "source_hash": "3e8285131a95ea8162b4568981fb4a22"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences Holdings, Inc. (MRVI) - Stock Analysis",
              "snippet": "Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2024 Earnings Call Transcript. Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Deb Hart - Head, Investor Relations Trey Martin - Chief Executive O...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:52:07.551393+00:00",
              "published_date": null,
              "source_hash": "c3e5d23a06016e7860f1f6e1fb5355ea"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences Holdings Inc (MRVI) Q3 2024 Earnings Call ...",
              "snippet": "Maravai LifeSciences Holdings Inc (NASDAQ:MRVI) has signed a definitive agreement to acquire the DNA and RNA businesses of PCNA BiTE, enhancing its mRNA offering for early-phase discovery work.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc regulatory compliance controversies",
              "retrieved_at": "2025-01-06T15:52:11.630171+00:00",
              "published_date": null,
              "source_hash": "be2375d5c91f7b1409122210df398432"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences Holdings, Inc. (MRVI) Company Profile & Overview ...",
              "snippet": "Company profile for Maravai LifeSciences Holdings, Inc. (MRVI) with a description, list of executives, contact details and other key facts. ... Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc regulatory compliance controversies",
              "retrieved_at": "2025-01-06T15:52:11.630111+00:00",
              "published_date": null,
              "source_hash": "96c04176548e25ec97f3e2c00746df9b"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences Holdings, Inc. - Dun & Bradstreet",
              "snippet": "Find company research, competitor information, contact details & financial data for Maravai LifeSciences Holdings, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:52:07.551423+00:00",
              "published_date": null,
              "source_hash": "fdf2d8b02d61e3ad36735c307eea96e3"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences Holdings Inc - Company Profile and News",
              "snippet": "Maravai LifeSciences Holdings, Inc. operates as a holding company. The Company, through its subsidiaries, focuses on providing critical products to enable the development of drug therapies ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc regulatory compliance controversies",
              "retrieved_at": "2025-01-06T15:52:11.630150+00:00",
              "published_date": null,
              "source_hash": "7705237638ac194aca53fc55f4760e8c"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Sold by Jane Street Group LLC",
              "snippet": "Jane Street Group LLC decreased its position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 73.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc regulatory compliance controversies",
              "retrieved_at": "2025-01-06T15:52:14.184461+00:00",
              "published_date": "2025-01-05T07:22:00+00:00",
              "source_hash": "54f1395aeee66cb75c1dfb9523c04bc8"
            },
            {
              "url": "",
              "title": "Maravai Lifesciences Holdings, Inc. Class A",
              "snippet": "Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc regulatory compliance controversies",
              "retrieved_at": "2025-01-06T15:52:14.184501+00:00",
              "published_date": "2024-01-08T14:07:00+00:00",
              "source_hash": "445df4305fea4937950db7ac2b08fc84"
            },
            {
              "url": "",
              "title": "RGA Investment Advisors Highlights Maravai LifeSciences Holdings, Inc. (MRVI) in Q1 2024 Letter",
              "snippet": "In this article, we are going to take a look at where Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) stands against the other best biotech stocks to buy under $20. The biotechnology industry is ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc supply chain disruptions",
              "retrieved_at": "2025-01-06T15:52:10.087111+00:00",
              "published_date": "2024-10-09T12:06:00+00:00",
              "source_hash": "fe81b7ba5615b1abc51c505738f878a1"
            },
            {
              "url": "",
              "title": "23,252 Shares in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Purchased by XTX Topco Ltd",
              "snippet": "XTX Topco Ltd acquired a new position in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) during the third quarter, Holdings Channel.com reports. The institutional ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc regulatory compliance controversies",
              "retrieved_at": "2025-01-06T15:52:14.184530+00:00",
              "published_date": "2024-12-21T00:00:00+00:00",
              "source_hash": "ad135f29f920aa7b2de41e8f5986c7be"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences Holdings, Inc. (MRVI)",
              "snippet": "Maravai LifeSciences is a leading life sciences company providing critical products to enable the development of novel vaccines, drug therapies, and diagnostics, and to support research on human diseases. ... regulatory approval and commercial release. ... Maravai LifeSciences Holdings, Inc. 10770 Wateridge Circle Suite 200",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc regulatory compliance controversies",
              "retrieved_at": "2025-01-06T15:52:11.629980+00:00",
              "published_date": null,
              "source_hash": "f55b97cc3e3d015ace423ce8167f94df"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences Holdings, Inc. (MRVI) - Stock Analysis",
              "snippet": "Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc regulatory compliance controversies",
              "retrieved_at": "2025-01-06T15:52:11.630093+00:00",
              "published_date": null,
              "source_hash": "6b7a9d337ff8ac5bb16c754c1b696502"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences",
              "snippet": "Maravai's brands are the proven catalysts for helping biotech, biopharma, and life science companies across the globe to realize the next generation of novel vaccines, therapeutics, and diagnostics.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc regulatory compliance controversies",
              "retrieved_at": "2025-01-06T15:52:11.630125+00:00",
              "published_date": null,
              "source_hash": "e4232e97de85f33ad1934e156171fa74"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences Holdings, Inc. (MRVI) - Yahoo Finance",
              "snippet": "See the company profile for Maravai LifeSciences Holdings, Inc. (MRVI) including business summary, industry/sector information, number of employees, business summary, corporate governance, key ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc regulatory compliance controversies",
              "retrieved_at": "2025-01-06T15:52:11.630139+00:00",
              "published_date": null,
              "source_hash": "35207d3d1c56dbbd3cbba22a2c70be55"
            },
            {
              "url": "",
              "title": "Who we are - Maravai LifeSciences",
              "snippet": "Maravai LifeSciences is helping biotech, biopharma and life sciences companies everywhere deliver novel vaccines, therapeutics and diagnostics. ... and we are committed to meeting or exceeding all applicable environmental regulatory compliance requirements and continuously improving the sustainability of our operations. Our environment, social ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc regulatory compliance controversies",
              "retrieved_at": "2025-01-06T15:52:11.630183+00:00",
              "published_date": null,
              "source_hash": "e47fe28e1e4b07dddd0f7e48793697a8"
            },
            {
              "url": "",
              "title": "Maravai LifeSciences Holdings, Inc. (MRVI) Statistics & Valuation ...",
              "snippet": "Detailed statistics for Maravai LifeSciences Holdings, Inc. (MRVI) stock, including valuation metrics, financial numbers, share information and more.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc regulatory compliance controversies",
              "retrieved_at": "2025-01-06T15:52:11.630194+00:00",
              "published_date": null,
              "source_hash": "6a087ff640957fbeea00f84188917a71"
            },
            {
              "url": "",
              "title": "RGA Investment Advisors Highlights Maravai LifeSciences Holdings, Inc. (MRVI) in Q1 2024 Letter",
              "snippet": "In this article, we are going to take a look at where Maravai LifeSciences Holdings, Inc. (NASDAQ ... policy recommendations to streamline the regulatory process for biotechnology products.",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Maravai Lifesciences Holdings Inc Maravai Lifesciences Holdings Inc regulatory compliance controversies",
              "retrieved_at": "2025-01-06T15:52:14.184522+00:00",
              "published_date": "2024-10-09T12:06:00+00:00",
              "source_hash": "a955c7919a28d13ef5892beffbbd3fd1"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "Maravai Lifesciences Holdings Inc post-pandemic revenue decline",
              "rationale": "Investigate the financial impact of declining COVID-19-related demand and its implications for future growth",
              "priority": 1
            },
            {
              "category": "financial_legal",
              "query": "Maravai Lifesciences Holdings Inc supply chain disruptions",
              "rationale": "Assess risks related to raw material dependencies and potential supply chain vulnerabilities",
              "priority": 2
            },
            {
              "category": "ethical_social",
              "query": "Maravai Lifesciences Holdings Inc regulatory compliance controversies",
              "rationale": "Examine potential regulatory challenges and their impact on product approvals and market access",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T08:52:32.427629",
        "data_confidence": 80,
        "pattern_confidence": null
      }
    }
  ]
}